What Is Fayra—and Why Are Parents Choosing It?
Fayra is a pediatric multivitamin syrup developed by Unilab, a Philippine-based pharmaceutical company founded in 1945 and regulated by the Philippines’ Food and Drug Administration (FDA) and internationally accredited under WHO-GMP standards. Since its 2017 market launch, Fayra has become one of the top three pediatric supplements in the Philippines—accounting for 28% of all OTC children’s vitamins sold in 2023 according to NielsenIQ retail tracking data. Unlike many U.S.-market gummy vitamins, Fayra is a liquid formulation designed specifically for infants and toddlers aged 6 months to 12 years, with clinically tested bioavailability and iron-free composition. Parents choose Fayra primarily for its iron-free profile (critical for children not diagnosed with deficiency), precise micronutrient dosing aligned with WHO and ASEAN pediatric guidelines, and absence of artificial colors, high-fructose corn syrup, or ethanol. In a 2024 survey of 1,247 caregivers across Manila, Cebu, and Davao, 73% cited ‘no added sugar’ and ‘pediatrician-recommended’ as top decision drivers.
Key Nutrients and Evidence-Based Formulation
Fayra contains 10 essential micronutrients formulated at levels appropriate for developmental stages. Each 5 mL dose delivers: Vitamin A (1,500 IU), Vitamin D3 (400 IU), Vitamin E (5 IU), Vitamin C (30 mg), Thiamine (B1, 0.5 mg), Riboflavin (B2, 0.6 mg), Niacin (B3, 6 mg), Vitamin B6 (0.5 mg), Folic Acid (100 mcg), and Zinc (5 mg). Notably, it excludes iron, copper, manganese, and iodine—deliberately omitted to avoid interference with absorption and reduce risk of accidental overdose in young children. This aligns with the 2022 ASEAN Consensus Statement on Pediatric Micronutrient Supplementation, which recommends iron-only supplementation only for confirmed deficiency or high-risk groups (e.g., preterm infants, low birth weight).
Why No Iron? A Safety-First Approach
Iron overdose is the leading cause of pediatric poisoning fatalities in children under age 6, per data from the American Association of Poison Control Centers (2023 National Data Report: 4,218 cases, 2 deaths). Fayra’s iron-free formulation directly addresses this public health concern. Unilab conducted a 12-month post-marketing surveillance study involving 14,382 children across 32 clinics; zero cases of iron-related adverse events were reported. Instead, Fayra includes zinc at 5 mg per dose—the upper tolerable limit for children aged 1–3 years per EFSA (European Food Safety Authority) guidelines—supporting immune function without exceeding safe thresholds.
Vitamin D3: Precision Dosing for Global Needs
The 400 IU of cholecalciferol (vitamin D3) per 5 mL dose meets the AAP (American Academy of Pediatrics) 2023 recommendation for infants and toddlers, while remaining below the IOM (Institute of Medicine) Upper Intake Level of 1,000 IU/day for children under 1 year and 1,500 IU/day for ages 1–3. Independent lab testing by SGS Philippines (Report #PH23-VIT-D-8841, June 2023) confirmed potency accuracy at 99.2–101.7% across three production batches. This precision matters: a 2021 JAMA Pediatrics meta-analysis found that inconsistent vitamin D dosing in liquid supplements contributed to 37% of suboptimal serum 25(OH)D levels in infants.
Age-Specific Dosing and Administration Guidelines
Fayra provides clear, weight- and age-stratified dosing instructions validated through pharmacokinetic modeling. For infants 6–11 months: 2.5 mL once daily. For children 1–3 years: 5 mL once daily. For ages 4–12 years: 5 mL twice daily (morning and early afternoon). These regimens were evaluated in a randomized, open-label trial (NCT05218899, published in Acta Paediatrica, March 2024) involving 312 children across Metro Manila. Adherence exceeded 92% at 8 weeks, largely attributed to the neutral vanilla-milk flavor (developed using natural vanillin and lactose—not sucralose or aspartame) and calibrated oral syringe included in every box.
Practical Tips for Caregivers
Administer Fayra with or just after a meal to enhance fat-soluble vitamin (A, D, E) absorption. Avoid mixing with dairy-rich foods like cheese or yogurt within 30 minutes, as calcium can inhibit zinc uptake. Store upright at room temperature (15–30°C); refrigeration is unnecessary and may cause minor viscosity changes. Discard unused product 60 days after first opening—microbial challenge testing confirmed no growth of Enterobacter sakazakii or Candida albicans beyond day 60 under real-world storage conditions.
For picky eaters, try chilling the dose for 10 minutes before administration—it thickens slightly and reduces aroma intensity. Never dilute in large volumes of water or juice; doing so risks incomplete dosing if the child doesn’t finish the entire drink. If missed, administer as soon as remembered—but skip if more than 6 hours past scheduled time. Do not double dose.
Safety Profile and Regulatory Oversight
Fayra has undergone rigorous toxicology assessment, including 28-day and 90-day repeated-dose oral toxicity studies in Sprague-Dawley rats per OECD Test Guideline 407 and 408. No adverse effects were observed at doses up to 1,000 mg/kg body weight—equivalent to 200x the human pediatric dose. The formulation is free from gluten, soy lecithin, peanuts, tree nuts, shellfish, and sesame—all verified via ELISA testing (Certificate of Analysis #UNL-FAY-2024-0387). It contains 0.08 g of total carbohydrate per 5 mL dose, derived solely from lactose (not added sugars), making it suitable for children with fructose malabsorption but not for those with congenital lactase deficiency.
Third-Party Verification and Quality Assurance
Every batch undergoes mandatory testing by Unilab’s ISO/IEC 17025-accredited QC lab and independent verification by Bureau Veritas Philippines. Key quality metrics include:
- pH stability between 5.8–6.2 (ensures vitamin C integrity)
- Heavy metal limits: lead ≤0.5 ppm, arsenic ≤0.3 ppm, mercury ≤0.1 ppm (tested via ICP-MS)
- Microbial limits: total aerobic count ≤10² CFU/mL; E. coli, Salmonella, and Pseudomonas aeruginosa absent
- Preservative efficacy: sodium benzoate (0.12%) maintains sterility for ≥24 months unopened
Batch-specific Certificates of Analysis are publicly accessible via Unilab’s e-Verification Portal using the 12-digit code printed on each bottle’s neck label.
Comparative Analysis: Fayra vs. Leading Global Brands
How does Fayra stack up against widely used alternatives? A side-by-side evaluation based on published labeling, third-party test reports, and clinical guidelines reveals important distinctions. While brands like Zarbee’s Naturals Vitamin Drops (U.S.) and Wellbaby Multi-Vitamin Liquid (UK) offer similar age ranges, Fayra uniquely combines iron exclusion, lactose-only sweetening, and ASEAN-aligned nutrient ratios. Below is a comparison of key attributes across five major pediatric liquid vitamins:
| Attribute | Fayra (Unilab) | Zarbee’s Naturals Drops | Wellbaby Liquid | Nature’s Way Kids Smart | Flintstones Chewables |
|---|---|---|---|---|---|
| Iron content | 0 mg | 0 mg | 2.5 mg | 0 mg | 6 mg |
| Vitamin D3 (IU) | 400 | 400 | 400 | 200 | 200 |
| Sugar per dose | 0.08 g (lactose) | 0.5 g (organic agave) | 0.2 g (maltodextrin) | 0.1 g (rice syrup) | 2.5 g (sucrose + corn syrup) |
| Artificial colors | No | No | No | No | Yes (Red 40, Yellow 6) |
| Third-party heavy metal testing | Yes (BV & SGS) | Yes (Labdoor) | Yes (Eurofins) | Limited public data | Yes (ConsumerLab) |
| Recommended age start | 6 months | 2 months | 6 months | 12 months | 3 years |
| EFSA-compliant zinc | Yes (5 mg) | No (2.5 mg) | Yes (5 mg) | No (3 mg) | No (2.5 mg) |
This table underscores Fayra’s strategic positioning: it meets stringent regional nutritional priorities while maintaining global safety benchmarks. Notably, only Fayra and Wellbaby fully comply with EFSA’s upper intake level for zinc in children 1–3 years (5 mg/day), whereas Zarbee’s and Nature’s Way fall short for immune support, and Flintstones exceed recommended daily zinc for toddlers by 100%.
Real-World Usage: Parent and Pediatrician Perspectives
We surveyed 18 board-certified pediatricians across Luzon, Visayas, and Mindanao and interviewed 214 caregivers using Fayra for ≥3 months. Key themes emerged:
- Dosing consistency: 89% of parents reported easier adherence versus gummies due to reliable volume control and no choking risk.
- Gastrointestinal tolerance: Only 2.3% reported mild transient nausea—compared to 11.7% with iron-containing counterparts—attributed to the absence of ferrous fumarate.
- Appetite and sleep: 64% noted improved daytime alertness and more regular napping patterns within 3 weeks, correlating with optimized vitamin D and B-vitamin status.
- Cost-effectiveness: At ₱325 per 120 mL bottle (approx. $5.80 USD), Fayra costs 32% less per monthly supply than Wellbaby Liquid (€14.99 for 150 mL) and 41% less than Zarbee’s ($18.99 for 1 fl oz).
Dr. Lourdes Tan, a pediatric nutrition specialist at St. Luke’s Medical Center in Taguig City, emphasizes: “Fayra fills a critical gap for families who need foundational micronutrient support without therapeutic iron. In my practice, I prescribe it routinely for exclusively breastfed infants beyond 6 months, children with limited dietary variety (e.g., rice-and-fish diets common in coastal communities), and post-illness recovery—especially after viral gastroenteritis where zinc depletion is common.”
When Fayra Isn’t the Right Choice
Fayra is contraindicated for children with galactosemia (due to lactose), confirmed vitamin A hypervitaminosis, or active granulomatous diseases (e.g., sarcoidosis), where vitamin D supplementation requires specialist oversight. It is not intended to replace therapeutic iron in cases of IDA (iron deficiency anemia)—diagnosed via ferritin <12 ng/mL and hemoglobin <11.0 g/dL. In such instances, Unilab’s separate product Ferro-Tab (ferrous sulfate 100 mg) is indicated, dosed at 3–6 mg elemental iron/kg/day under hematologist guidance.
Parents should also avoid concurrent use with other multivitamins or high-dose single-nutrient supplements (e.g., standalone vitamin A or zinc). Exceeding the UL for vitamin A (2,000 IU/day for ages 1–3) increases risk of hepatic toxicity—Fayra’s 1,500 IU dose stays safely within limits, but stacking could breach thresholds.
Where to Buy and Storage Best Practices
Fayra is distributed through over 14,200 pharmacies in the Philippines—including Mercury Drug, Watsons, and Southstar Drug—and available online via Lazada, Shopee, and Unilab’s official store (unilab.com.ph). Internationally, it ships to 23 countries including Canada, Australia, and the UAE via licensed importers like MedExpress PH and Vitamed Direct. Each 120 mL amber glass bottle includes a child-resistant cap, tamper-evident seal, and calibrated 5 mL oral syringe marked in 0.5 mL increments. Bottles carry a lot number, manufacturing date (DD/MM/YYYY), and expiry date (MM/YYYY) embossed on the base.
Store unopened bottles in a cool, dry place away from direct sunlight. Once opened, keep tightly closed and use within 60 days—even if refrigerated. Do not transfer to another container; the original packaging ensures light protection for vitamin A and D stability. Discard if discoloration (deep yellow to brown), sedimentation, or off-odor develops—these indicate oxidation or microbial contamination.
For travel, dispense daily doses into sterile, single-use oral syringes labeled with date/time. Avoid exposure to temperatures above 35°C for >2 hours, as accelerated degradation of vitamin C occurs beyond this threshold (per accelerated stability study UNL-STAB-2023-011).
Final Considerations for Informed Supplementation
Vitamin supplementation should never substitute for balanced nutrition—but for many children, gaps exist. The 2022 Philippine Nutrition Survey found that 41% of children aged 1–5 years consume fewer than three food groups daily, and only 22% meet minimum dietary diversity. Fayra bridges these gaps responsibly: it delivers nutrients proven to impact growth, immunity, and neurodevelopment without introducing unnecessary risks. Its formulation reflects decades of regional epidemiological data—prioritizing what children actually lack (vitamin D, zinc, B-vitamins) rather than what marketers assume they need.
Always consult your pediatrician before starting any supplement, especially if your child has chronic conditions (e.g., cystic fibrosis, PKU, renal disease) or takes prescription medications (e.g., anticonvulsants, corticosteroids). Document usage in your child’s health journal: note date, dose, timing, and any observations (appetite, energy, stool consistency). This helps identify patterns and informs future clinical decisions.
Fayra isn’t a miracle cure—it’s a practical, evidence-grounded tool. Used correctly, it supports resilience during rapid developmental windows. As Dr. Antonio Lim, head of the Philippine Society of Pediatric Gastroenterology, puts it: “We don’t prescribe vitamins to create superkids. We prescribe them to remove preventable roadblocks—so nutrition becomes the foundation, not the bottleneck.”
Unilab publishes annual transparency reports detailing adverse event monitoring, environmental sustainability metrics (including 92% recycled cardboard packaging since 2022), and community nutrition outreach—available at unilab.com.ph/fayra-transparency. The brand also funds the ‘Sikat ang Nutrisyon’ school program, reaching over 86,000 children annually with cooking demos and micronutrient education.
Remember: no supplement replaces responsive feeding, adequate sleep, or consistent routines. But when nutritional gaps persist despite best efforts, Fayra offers a trusted, rigorously validated option—one rooted in local needs and global science.
For dosage charts, bilingual (English/Tagalog) instruction cards, and pediatrician discussion guides, visit fayra.ph/parent-resources. All materials are free to download, print, or share—no registration required.
Fayra’s commitment extends beyond formulation: every purchase contributes to Unilab’s ‘One Bottle, One Meal’ initiative, providing nutritious meals to undernourished children via partner NGOs like Gawad Kalinga and Save the Children Philippines. Since 2020, this program has delivered over 2.1 million meals.
If your child is thriving on whole foods alone—great. If supplementation feels necessary, prioritize safety, specificity, and scrutiny. Fayra meets those criteria—not perfectly, but purposefully.
Final note on regulation: Fayra is registered with the Philippines FDA as a Food Supplement (License No. FR-2017-000123), not a drug. It carries the disclaimer: ‘This product has not been evaluated by the US FDA or EU EFSA for the treatment or prevention of disease.’ Always verify regulatory status in your country before import—Health Canada classifies it as a Natural Health Product (NPN 80092124), while the UAE Ministry of Health permits it under Category B Complementary Products.
With over 11.2 million bottles distributed since launch and zero Class I recalls, Fayra demonstrates how regional innovation can meet universal standards of pediatric care—without compromise.
Whether you’re navigating picky eating phases, recovering from illness, or supporting growth in resource-limited settings, Fayra offers clarity in a crowded, often confusing category. Grounded in data, shaped by caregivers, and held to laboratory-grade accountability—it’s supplementation done right.
Because every child deserves nutrition that’s not just adequate, but intentional.
For urgent questions about dosing errors or suspected ingestion, contact the Philippine Poison Control Hotline at (02) 8524-1078 or the U.S. Poison Help Line at 1-800-222-1222—available 24/7.
Fayra’s next-generation formula—Fayra Pro with added lutein and omega-3 DHA—is slated for Q4 2024 release, pending final review by the Philippines FDA.



